ストックスクリーナーアプリを入手
66.25
0.68%
0.45
アフターアワーズ：
66.70
0.45
+0.68%
Cytokinetics Inc (CYTK) 最新ニュース
Insider Sell Alert: Fady Malik Sells 3,500 Shares of Cytokinetics Inc (CYTK) - GuruFocus
Cytokinetics EVP Malik sells $229,915 of company stock By Investing.com - Investing.com Australia
Cytokinetics EVP Malik sells $229,915 of company stock - Investing.com
Cytokinetics (CYTK) EVP sells 3,500 shares after option exercise - Stock Titan
Cytokinetics to Announce First Quarter Results on May 5, 2026 - Yahoo Finance
Can Myqorzo drive growth for Cytokinetics amid competition? - MSN
Cytokinetics Inc stock (US2328281044): Does its cardiac muscle inhibitor pipeline now become the tur - AD HOC NEWS
Cytokinetics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Cytokinetics awards equity grants to 33 new hires under Nasdaq rule - Stock Titan
Cytokinetics, Inc. (CYTK) Stock Analysis: A 39% Potential Upside In The Biotech Arena - DirectorsTalk Interviews
Surf Air, Cytokinetics, ASE, Itau, Clene Insider Shake-Up - TipRanks
Cytokinetics Incorporated : 2025 Annual Report of 2025 - marketscreener.com
[DEF 14A] CYTOKINETICS INC Definitive Proxy Statement - Stock Titan
Can Myqorzo Drive Growth for Cytokinetics Amid Competition? - Yahoo Finance
CYTK SEC FilingsCytokinetics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Cytokinetics Insider Sold Shares Worth $491,783, According to a Recent SEC Filing - Moomoo
Massachusetts Financial Services Co. MA Cuts Position in Cytokinetics, Incorporated $CYTK - MarketBeat
Insider Sell: Andrew Callos Sells 7,449 Shares of Cytokinetics I - GuruFocus
Cytokinetics (CYTK) CEO Robert Blum sells 7,500 shares, retains large stake - Stock Titan
Blum Robert I, president & CEO of Cytokinetics, sells $490k in stock - Investing.com
Director at CYTOKINETICS (CYTK) receives 95-share equity grant in lieu of cash - Stock Titan
Cytokinetics EVP Callos sells $491k in stock By Investing.com - Investing.com India
Blum Robert I, president & CEO of Cytokinetics, sells $490k in stock By Investing.com - Investing.com South Africa
Cytokinetics (NASDAQ: CYTK) director receives 95-share equity grant - Stock Titan
[Form 4] CYTOKINETICS INC Insider Trading Activity - Stock Titan
CYTOKINETICS (NASDAQ: CYTK) director receives 191-share equity grant as retainer - Stock Titan
Cytokinetics EVP Callos sells $491k in stock - Investing.com
Andrew Callos Sells 7,449 Shares of Cytokinetics (NASDAQ:CYTK) Stock - MarketBeat
CYTOKINETICS (CYTK) EVP Andrew Callos sells 7,449 shares in open market - Stock Titan
Andrew Callos sells via 10b5-1; CYTK (NASDAQ: CYTK) insider filings - Stock Titan
Cytokinetics Incorporated : Read Our 2025 Report - marketscreener.com
Cytokinetics Highlights MYQORZO Launch Progress, Teases 2026 Phase 3 Readout at Needham Conference - MarketBeat
Cytokinetics Inc stock (US2328281044): Does cardiac muscle therapy execution now define its biotech - AD HOC NEWS
Fed Watch: Is Cytokinetics Incorporated undervalued by DCF analysisSwing Trade & Verified Short-Term Plans - baoquankhu1.vn
CYTK Analyst Rating: Wells Fargo Initiates Overweight April 2026 - Meyka
Cytokinetics Inc at Barclays Global Healthcare Conference Transcript - GuruFocus
Q1 2025 Cytokinetics Inc Earnings Call Transcript - GuruFocus
Cytokinetics Inc at JMP Securities Life Sciences Conference Transcript - GuruFocus
Q3 2025 Cytokinetics Inc Earnings Call Transcript - GuruFocus
Cytokinetics Inc (HAM:KK3A) Stock Earnings Transcripts - GuruFocus
Cytokinetics Inc (HAM:KK3A) Stock News, Headlines & Updates - GuruFocus
Market Review: What are the future prospects of Cytokinetics IncorporatedAnalyst Downgrade & Real-Time Price Movement Reports - baoquankhu1.vn
Wells Fargo initiates coverage of Cytokinetics (CYTK) with overweight recommendation - MSN
CYTK Initiates Coverage On Wells Fargo -- Rating Set to Overweig - GuruFocus
Momentum Shift: Is Cytokinetics Incorporated stock heavily shortedWeekly Profit Analysis & Scalable Portfolio Growth Methods - baoquankhu1.vn
Risk Recap: Will Cytokinetics Incorporated stock go up in YEAR2026 Pullback Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Cytokinetics Inc (HAM:KK3A) Valuation: Possible Value Trap, Think Twice - GuruFocus
Cytokinetics Inc (HAM:KK3A) Stock Price, Trades & News - GuruFocus
Who's Buying or Selling Cytokinetics Inc (HAM:KK3A) Stock Today? - GuruFocus
Cytokinetics Inc Stock Operating Data - GuruFocus
Cytokinetics (CYTK) EVP Malik sells $292,985 in stock By Investing.com - Investing.com India
Cytokinetics (CYTK) EVP Malik sells $292,985 in stock - Investing.com
Insider Sell: Fady Malik Sells 4,500 Shares of Cytokinetics Inc (CYTK) - GuruFocus
Cytokinetics Insider Sold Shares Worth $292,985, According to a Recent SEC Filing - marketscreener.com
Cytokinetics (CYTK) EVP nets 4,500-share sale after option exercises - Stock Titan
CYTK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CYTK (NASDAQ: CYTK) insider sale filing lists 22,000-share option exercise - Stock Titan
Cytokinetics, Incorporated (CYTK) stock price, news, quote and history - Yahoo Finance Australia
Cytokinetics, Incorporated (CYTK) Stock Price, News, Quote & History - Yahoo! Finance Canada
2.53%
2.69%
大文字化:
|
ボリューム (24 時間):